SCHEMBL1982913

SCHEMBL1982913

Cc1ccccc1-c1c(Cl)[c]ccc1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 1/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
TSHR P16473 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP1A2 P05177 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP1A1 P04798 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2320148 0.85 PLA2G7 (0.36) PLA2G7NPC1RAB9ATSHRHPGD
SCHEMBL9729126 0.82 CYP2A6 (0.41) NPC1RAB9ATSHRHPGDHSD17B10
SCHEMBL2316025 0.82 PLA2G7 (0.34) PLA2G7NPC1RAB9ATSHRHPGD
SCHEMBL9040663 0.80 MEN1 (0.35) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL10889222 0.80 ALDH1A1 (0.37) NPC1RAB9ATSHRHPGDHSD17B10
SCHEMBL10621165 0.79 NOTUM (0.39) CASP3HSD11B1NOTUM
SCHEMBL14975950 0.78 ALDH1A1 (0.38) NPC1RAB9ATSHRHPGDSMN1; SMN2
SCHEMBL14976063 0.78 C1R (0.31)
SCHEMBL14975620 0.78 PTPRC (0.36) CYP1A2CYP2C19PTGS1PTGS2HSD11B1
SCHEMBL8309994 0.77 APP (0.44) TSHRHSD17B10MEN1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011072207-A1 AZOCYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-16 WO disclosed